Literature DB >> 3495598

IgM binding protein expressed by activated B cells.

S K Sanders, H Kubagawa, T Suzuki, J L Butler, M D Cooper.   

Abstract

We have identified an IgM binding protein, a single chain polypeptide of Mr 60,000, that is expressed on the surface of B lymphocytes within 18 hr following their activation with phorbol myristate acetate. The IgM binding protein was also detected on fresh leukemic B cells from individuals with chronic lymphocytic leukemia, and the level of its expression was increased after phorbol myristate acetate activation. Resting and phorbol myristate acetate-activated T cells, monocytes, and polymorphonuclear leucocytes did not express detectable amounts of the IgM binding protein. The 60-kDa protein on activated human B cells could bind secreted IgM molecules of both mouse and human origin, as well as endogenous membrane-bound IgM molecules following their cross-linkage with anti-mu antibodies. The binding of soluble IgM molecules to the surface of activated B cells was also demonstrated by indirect immunofluorescence analysis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495598

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

Review 2.  The long elusive IgM Fc receptor, FcμR.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; Dewitt Jones; Naonori Nishida; Toshio Miyawaki; Luigi F Bertoli; Sheila K Sanders; Kazuhito Honjo
Journal:  J Clin Immunol       Date:  2014-05-03       Impact factor: 8.317

3.  Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.

Authors:  Fu Jun Li; Yoshiki Kubagawa; Matthew K McCollum; Landon Wilson; Tomoko Motohashi; Luigi F Bertoli; James C Barton; Stephen Barnes; Randall S Davis; Hiromi Kubagawa
Journal:  Blood       Date:  2011-09-09       Impact factor: 22.113

4.  Monoclonal antibodies specific for human IgM Fc receptor inhibit ligand-binding activity.

Authors:  Yoshiki Kubagawa; Kazuhito Honjo; Dong-Won Kang; Hiromi Kubagawa
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-12

5.  Unique ligand-binding property of the human IgM Fc receptor.

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; John F Kearney; Hiromi Kubagawa
Journal:  J Immunol       Date:  2015-01-19       Impact factor: 5.422

6.  Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice.

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; Yusuke Suzuki; Miyuki Takagi; Hiroshi Ohno; R Pat Bucy; Shozo Izui; Hiromi Kubagawa
Journal:  Int Immunol       Date:  2014-07-03       Impact factor: 4.823

7.  Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor.

Authors:  Kaoru Kikuno; Dong-Won Kang; Kazuki Tahara; Ikuko Torii; Homare M Kubagawa; Kang Jey Ho; Lucie Baudino; Naoto Nishizaki; Akira Shibuya; Hiromi Kubagawa
Journal:  Eur J Immunol       Date:  2007-12       Impact factor: 5.532

8.  Biochemical nature of an Fc mu receptor on human B-lineage cells.

Authors:  T Ohno; H Kubagawa; S K Sanders; M D Cooper
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

Review 9.  Functional Roles of the IgM Fc Receptor in the Immune System.

Authors:  Hiromi Kubagawa; Kazuhito Honjo; Naganari Ohkura; Shimon Sakaguchi; Andreas Radbruch; Fritz Melchers; Peter K Jani
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

10.  Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; G Larry Gartland; Luigi F Bertoli; Hiromi Mori; Hiroyuki Takatsu; Toshio Kitamura; Hiroshi Ohno; Ji-Yang Wang
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.